Business Context and Reporting Period
This Form 8-K is filed by DarioHealth Corp. (DRIO) on July 9, 2021, reporting events occurring on July 8, 2021. The company is incorporated in Delaware and trades on The Nasdaq Capital Market. The filing addresses a legal matter regarding the company's bylaws and a related class action lawsuit.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and legal proceedings rather than financial performance.
Material Changes
On July 8, 2021, the Delaware Chancery Court issued an order invalidating Article 3, Section 3.3 of the Company's bylaws. This provision previously permitted the Board of Directors to remove a director with or without cause. The court struck the provision from the bylaws, deeming it null and void. This change resolves a putative class action commenced in January 2021, which alleged the provision violated Delaware Corporate Law.
Outlook, Risks, and Management Commentary
Management believes the class action lawsuit will be resolved in its entirety following the court's order. The filing does not contain forward-looking guidance, financial outlook, or discussion of other risks or contingencies beyond the resolved bylaw dispute.
Key Facts for Investor Verification
- The bylaw provision allowing the Board to remove directors without cause has been invalidated by the Delaware Chancery Court.
- The related class action lawsuit initiated in January 2021 is expected to be fully resolved.
- The company's Articles of Incorporation or Bylaws have been amended as a result of the court order.
- No financial data or operational metrics are disclosed in this specific filing.